Brett Favre Turns to a Controversial Treatment for Parkinson’s Disease

In September, Favre revealed his diagnosis with Parkinson’s disease. Now, he’s working to find treatment solutions.

Favre joined a Neuroregenerative Program in Mexico to explore how ibogaine treatment might help manage early symptoms, as reported by Marca.

Ibogaine is naturally occurring psychedelic compound which is being studied as a potential treatment for both traumatic brain injury and multiple sclerosis.

“I was told about ibogaine from a friend who completed the treatment,” Favre said. “And was blown away by the results.”

The program focuses on regenerating damaged neural tissue by blending plant-based medicine with neuroscience and clinical supervision.

But, the treatment is not FDA-approved and remains controversial within the medical community.

“Since coming to Mexico and treatment, I’ve felt a real shift, especially in my sleep and energy,” Favre said.

Favre joins a long list of football players facing the lasting effects of CTE and related neurological challenges after their careers. And he’s expressed concerns about what the future holds for him, likely inspiring him to take matters into his own hands.

“It makes me wonder what the future brings for me. I’ve already been diagnosed with Parkinson’s. I often wonder—and I try not to, but I can’t help it—what the future holds,” Favre previously shared.

Now, he’s encouraging others—especially fellow athletes facing similar struggles—to consider giving ibogaine a try.

“I will say about it, it’s not necessarily the present, it’s life after and residual effects that so many people have spoken highly of. If you are contemplating it, come do it,” he said.

Kelsey Kryger, C.P.T.